Lv4
460 积分 2023-08-02 加入
Mechanisms, functions and therapeutic targeting of protein tyrosine phosphatases
1个月前
已完结
The expanding landscape of canonical and non-canonical protein phosphorylation
1个月前
已完结
Beyond Proteolysis-Targeting Chimeric Molecules: Designing Heterobifunctional Molecules Based on Functional Effectors
1个月前
已完结
Proximity-inducing modalities: the past, present, and future
1个月前
已完结
Discovery of Asciminib (ABL001), an Allosteric Inhibitor of the Tyrosine Kinase Activity of BCR-ABL1
1个月前
已完结
The allosteric inhibitor ABL001 enables dual targeting of BCR–ABL1
2个月前
已完结
The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity
2个月前
已完结
Allosteric solution to the problems of undruggable targets, drug toxicity, and emerging resistance
2个月前
已关闭
Wandering beyond small molecules: peptides as allosteric protein modulators
2个月前
已完结
GPCR drug discovery: new agents, targets and indications
2个月前
已完结
皖公网安备34019202002308
